Original Biomedicals Co (ROCO:6483) LT-Debt-to-Total-Asset: 0.04 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6483 Original Biomedicals Co Ltd ROCO:6483
32 GF Score
Price NT$13.15
! 2 Warning Signs
View Full Analysis

What is Original Biomedicals Co LT-Debt-to-Total-Asset?

Original Biomedicals Co ROCO:6483 -1.87% 32 LT-Debt-to-Total-Asset is 0.04 as of Dec. 2025. GuruFocus rates ROCO:6483 with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Original Biomedicals Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.04.

Original Biomedicals Co's long-term debt to total assets ratio increased from Dec. 2024 (0.03) to Dec. 2025 (0.04). It may suggest that Original Biomedicals Co is progressively becoming more dependent on debt to grow their business.

Original Biomedicals Co  (ROCO:6483) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Original Biomedicals Co LT-Debt-to-Total-Asset Related Terms

Original Biomedicals Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Original Biomedicals Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Original Biomedicals Co LT-Debt-to-Total-Asset Chart

Original Biomedicals Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only 0.00 0.17 0.03 0.03 0.04

Original Biomedicals Co Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.03 0.02 0.04
ROCO:6483
32GF Score
Original Biomedicals Co Ltd ROCO:6483
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Original Biomedicals Co LT-Debt-to-Total-Asset Calculation

Original Biomedicals Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=7.029/183.935
=0.04

Original Biomedicals Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=7.029/183.935
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.04 mean?
Original Biomedicals Co (ROCO:6483) has a LT-Debt-to-Total-Asset of 0.04 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Original Biomedicals Co and its competitors.
Is Original Biomedicals Co's LT-Debt-to-Total-Asset too high?
Original Biomedicals Co's current LT-Debt-to-Total-Asset is 0.04. Overall, Original Biomedicals Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Original Biomedicals Co's LT-Debt-to-Total-Asset compare to ZTS and UTHR?
Original Biomedicals Co's LT-Debt-to-Total-Asset of 0.04 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Original Biomedicals Co and its competitors. Original Biomedicals Co's current LT-Debt-to-Total-Asset is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Original Biomedicals Co stock overvalued right now?
Original Biomedicals Co (ROCO:6483) has a current LT-Debt-to-Total-Asset of 0.04. The current LT-Debt-to-Total-Asset is 0.04. Original Biomedicals Co's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Original Biomedicals Co (ROCO:6483), the current LT-Debt-to-Total-Asset is 0.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Original Biomedicals Co Business Description

Address No. 9, Nanke 2nd Road, 2 Floor-1, Xinshi District, Tainan, TWN, 74147
Original Biomedicals Co Ltd is a biopharmaceutical company engaged in the research and development of drugs. The company focuses on developing new drug formulations, drug delivery systems, and repurposing existing pharmaceutical products.
32GF Score

Get the complete analysis for ROCO:6483

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.15
Price